
Rapport Therapeutics, Inc. Common Stock
USD41.80
+1.41 (+3.49%)
CEO
Abraham N. Ceesay
IPO Date
2024-06-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$40.40
Prev. Close
$40.39
Day Low
$39.69
Day High
$43.76
52W Low
$11.05
52W High
$43.75
Market Cap
$1.53B
Volume
0.42M
| Wells Fargo |
| Overweight |
| Overweight |
| maintain |
| 11 Mar 2026 | BTIG | Buy | Buy | maintain |
| 9 Dec 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 8 Dec 2025 | BTIG | Buy | Buy | maintain |
| 7 Nov 2025 | Citizens | Market Outperform | Market Outperform | maintain |
| 8 Sept 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 8 Jul 2025 | JMP Securities | Market Outperform | Market Outperform | maintain |